Clenbuterol increases muscle fiber size and GATA-2 protein in rat skeletal muscle in utero

Molecular Reproduction and Development

Volumn 75, Issue 5, 2008, Pages 785-794

  Downie, Diane ^a   Delday, Margaret I ^a   Maltin, Charlotte A ^a   Sneddon, Alan A ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

adrenergic agonist; Anabolism; Fetal; Hypertrophy

Indexed keywords

CLENBUTEROL; DNA; MUSCLE PROTEIN; PROTEIN KINASE C ALPHA; PROTEIN KINASE C THETA; RNA; TRANSCRIPTION FACTOR GATA 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DNA DETERMINATION; DRUG EFFECT; DRUG MECHANISM; FAST MUSCLE FIBER; FEMALE; GESTATION PERIOD; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ANALYSIS; SKELETAL MUSCLE; SLOW MUSCLE FIBER; UPREGULATION; WESTERN BLOTTING;

ADRENERGIC BETA-AGONISTS; ANIMALS; CELL SIZE; CLENBUTEROL; FEMALE; FETUS; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPERTROPHY; ISOENZYMES; MATERNAL-FETAL EXCHANGE; MUSCLE DEVELOPMENT; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; MUSCLE, SKELETAL; PREGNANCY; PROTEIN KINASE C; RATS; UP-REGULATION;

RATTUS;

EID: 41149085728     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.20795     Document Type: Article

References (42)

1. Awede BL, Thissen JP, Lebacq J. 2002. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab 282:E31-E37.
2. Burton K. 1956. A study of the conditions and mechanism of diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62:315-323.
3. Capiati DA, Limbozzi F, Téllez-Iñón MT, Boland RL. 1999. Evidence on the participation of protein kinase c α in the proliferation of cultured myoblasts. J Cell Biochem 74:292-300.
4. Choo JJ, Horan MA, Little RA, Rothwell NJ. 1989. Muscle wasting associated with endotoxemia in the rat: Modification by the beta 2-adrenoceptor agonist clenbuterol. Biosci Rep 9:615-621.
5. 2-adrenoceptor activation. Am J Physiol 263:E50-E56.
6. DiMario JX, Funk PE. 1999. Protein kinase C activity regulates slow myosin heavy chain 2 gene expression in slow lineage skeletal muscle fibers. Devel Dynamics 216:177-189.
7. Emery PW, Rothwell NJ, Stock MJ, Winter PD. 1984. Chronic effects of β-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep 4:83-89.
8. Florini JR, Roberts AB, Ewton DZ, Falen SL, Flanders KC, Sporn MB. 1986. Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. J Biol Chem 261:16509-16513.
9. Harris AJ, Fitzsimons RB, McEwan JC. 1989. Neural control of the sequence of expression of myosin heavy chain isoforms in fetal mammalian muscles. Development 107:751-769.
10. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, Palmer RM. 1992. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol; evidence for translational control. Comp Biochem Physiol C 102:23-27.
11. Hilgenberg L, Miles K. 1995. Developmental regulation of a protein kinase C isoform localized in the neuromuscular junction. J Cell Sci 108:51-61.
12. Hinkle RT, Hodge KM, Cody DB, Sheldon RJ, Kobilka BK, Isfort RJ. 2002. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor. Muscle Nerve 25:729-734.
13. Kelly AM, Zacks SI. 1969. The histogenesis of rat intercostal muscle. J Cell Biol 42:135-153.
14. 2+, phospholipid-dependent protein kinase associated with the plasma membrane. Nature 301:621-623.
15. Li MX, Jia M, Yang LX, Jiang H, Lanuza MA, Gonzalez CM, Nelson PG. 2004. The role of the theta isoform of protein kinase C (PKC) in activity-dependent synapse elimination: Evidence from the PKC theta knock-out mouse in vivo and in vitro. J Neurosci 24:3762-3769.
16. Liu JP. 1996. Protein kinase C and its substrates. Mol Cell Endocrinol 116:1-29.
17. Liu WS, Heckman CA. 1998. The sevenfold way of PKC regulation. Cell Signal 8:529-542.
18. Maltin CA, Delday MI, Reeds PJ. 1986. The effect of a growth promoting drug, clenbuterol, on fiber frequency and area in hind limb muscles of young male rats. Biosci Rep 6:293-299.
19. Maltin CA, Delday MI, Hay SM. 1990. The effect of clenbuterol administration in utero and throughout lactation on pre- and postnatal muscle development in the rat. Growth Dev Aging 54:143-150.
20. Martineau L, Little RA, Rothwell NJ, Fisher MI. 1993. Clenbuterol, a beta 2-adrenergic agonist, reverses muscle wasting due to scald injury in the rat. Burns 19:26-34.
21. McMillan DN, Noble BS, Maltin CA. 1992. The effect of the beta-adrenergic agonist clenbuterol on growth and protein metabolism in rat muscle cell cultures. J Anim Sci 70:3014-3023.
22. Minami T, Abid MR, Zhang J, King G, Kodama T, Aird WC. 2003. Thrombin stimulation of vascular adhesion molecule-1 in endothelial cells is mediated by protein kinase C (PKC)-delta-NF-kappa B and PKC-zeta-GATA signaling pathways. J Biol Chem 278:6976-6984.
23. Morton RH, Agbenyega ET, Hatton PA, Wareham AC. 1995. Effects of clenbuterol and ICI118551, a selective beta 2-antagonist, on the growth of skeletal muscle of suckling rats. Pflugers Arch 431:237-243.
24. Munro HN, Fleck A. 1969. Mammalian protein metabolism. New York: Academic Press.
25. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. 1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400:581-585.
26. Musaro A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL, Rosenthal N. 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 27:195-200.
27. O'Neill MC, Stockdale FE. 1972. Differentiation without cell division in cultured skeletal muscle. Dev Biol 29:410-418.
28. Osada S-I, Mizuno K, Saido TC, Suzuki K, Kuroki T, Ohno S. 1992. A new member of the protein kinase C family, nPKC-θ, predominantly expressed in skeletal muscle. Mol Cell Biol 12:3930-3938.
29. Paul AC, Rosenthal N. 2002. Different modes of hypertrophy in skeletal muscle fibers. J Cell Biol 156:751-760.
30. Pelkonen O, Tuimala R, Kauppila A. 1982. Placental transfer of clenbuterol early in human pregnancy. Eur J Clin Pharmacol 22:403-406.
31. Pullar JD, Webster JF. 1977. The energy cost of fat and protein deposition in the rat. Br J Nutr 37:355-363.
32. Reeds PJ, Hay SM, Dorward PM, Palmer RM. 1986. Stimulation of muscle growth by clenbuterol: Lack of effect on protein biosynthesis. Br J Nutr 56:249-256.
33. Rehfeldt C, Schadereit R, Weikard R, Reichel K. 1997. Effect of clenbuterol on growth, carcase and skeletal muscle characteristics in broiler chickens. Br Poult Sci 38:366-373.
34. Ricks CA, Dalrymple RH, Baker PK, Ingle DL. 1984. Use of a β-agonist to alter fat and muscle deposition in steers. J Anim Sci 59:1247-1256.
35. Rubinstein NA, Kelly AM. 1981. Development of muscle fiber specialization in the rat hindlimb. J Cell Biol 90:128-144.
36. Sneddon AA, Delday MI, Maltin CA. 2000. Amelioration of denervation-induced atrophy by clenbeuterol is associated with increased PKC-α activity. Am J Physiol Endocrinol Metab 279:E188-E195.
37. Sneddon AA, Delday MI, Steven J, Maltin CA. 2001. Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism. Am J Physiol Endocrinol Metab 281:E676-E682.
38. Spurlock DM, McDaneld TG, McIntyre LM. 2006. Changes in skeletal muscle gene expression following clenbuterol administration. BMC Genomics 7:320.
39. Tsushima H, Urata Y, Miyazaki Y, Fuchigami K, Kuriyama K, Kondo T, Tomonaga M. 1997. Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2. Cell Growth Diff 12:1317-1328.
40. Wigmore PM, Baillie HS, Khan M, Morrison EH, Mayhew TM. 1992. Nuclear number during muscle development. Muscle Nerve 15:1301-1302.
41. Zappelli F, Willems D, Osada S, Ohno S, Wetsel WC, Molinaro M, Cossu G, Bouche M. 1996. The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKC-theta: A possible molecular basis for myoblast diversification during limb histogenesis. Dev Biol 180:156-164.
42. Zeman RJ, Ludemann R, Etlinger JD. 1987. Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles. Am J Physiol 252:E152-E155.